DUSP14 attenuates airway inflammation and mucus hypersecretion in allergic asthma by regulating TAK1 activity
Authors:
- 29 May 2025
- journal article
- Published by Elsevier in Immunology Letters
- Vol. 276, 107047
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (QNPY2020012)
This publication has 21 references indexed in Scilit:
- Collagen Triple Helix Repeat Containing 1 Deficiency Protects Against Airway Remodeling and Inflammation in Asthma Models In Vivo and In VitroInflammation, 2023
- TAK1 of blunt snout bream promotes NF-κB activation via interaction with TAB1 in response to pathogenic bacteriaFish & Shellfish Immunology, 2022
- Asthma epidemiology and risk factorsSeminars in Immunopathology, 2020
- Post-translational Modification of OTULIN Regulates Ubiquitin Dynamics and Cell DeathCell Reports, 2019
- Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled AsthmaNew England Journal of Medicine, 2018
- AsthmaThe Lancet, 2018
- Lyn kinase represses mucus hypersecretion by regulating IL-13-induced endoplasmic reticulum stress in asthmaEBioMedicine, 2017
- Targeting key proximal drivers of type 2 inflammation in diseaseNature Reviews Drug Discovery, 2015
- Chagasic antibodies induce cardiac COX-2/iNOS mRNA expression with PGE2/NO productionInternational Journal of Cardiology, 2009
- Contemporaneous maturation of immunologic and respiratory functions during early childhood: Implications for development of asthma prevention strategiesJournal of Allergy and Clinical Immunology, 2005